You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

restarting oral antiviral therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial in Seoul (Standard of care)

Active, not recruiting
  • Chronic Hepatitis B
  • Standard of care
  • Seoul, Korea, Republic of
  • +3 more
Mar 29, 2023

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)

    Not yet recruiting
    • Chronic Hepatitis b
    • STSG-0002 Injection
    • Beijing, Beijing, China
    • +3 more
    Mar 6, 2023

    Hiv, Hormone Therapy Trial in San Diego (Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg, Emtricitabine Tenofovir

    Completed
    • Hiv
    • Hormone Therapy
    • Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg
    • Emtricitabine Tenofovir Alafenamide 200/25 mg
    • San Diego, California
      UC San Diego AntiViral Research Center (AVRC)
    Sep 21, 2022

    Corona Virus Infection, Middle East Respiratory Syndrome (MERS), Acute Respiratory Distress Syndrome Trial in Cairo (Lactoferrin

    Not yet recruiting
    • Corona Virus Infection
    • +5 more
    • Lactoferrin (Apolactoferrin)
    • Placebo of excipient(s) will be administered
    • Cairo, Giza, Egypt
    • +3 more
    Nov 12, 2021

    Chronic Hepatitis B Trial in Daegu (Experimental)

    Completed
    • Chronic Hepatitis B
    • Daegu, Korea, Republic of
      Daegu Chatholic University Medical center
    Jul 26, 2021

    Metabolic Syndrome on Antiviral Response in People With Chronic

    Not yet recruiting
    • Chronic Hepatitis b
      • (no location specified)
      Jan 21, 2023

      HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

      Recruiting
      • HIV-1-infection
      • Kisumu, Kenya
      • +6 more
      Feb 1, 2023

      Nirmatrelvir-ritonavir in Hospitalized Patients

      Recruiting
      • Hospitalized Patients
      • Hangzhou, Zhejiang, China
        Changcheng Shi
      Feb 26, 2023

      HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

      Recruiting
      • HIV Infections
      • +2 more
      • Letermovir 240 MG Oral Tablet
      • +2 more
      • Birmingham, Alabama
      • +18 more
      Jun 20, 2022

      Cytomegalovirus Anterior Uveitis Trial in San Francisco (Valganciclovir Hydrochloride, Ganciclovir Sodium, Placebo Oral Tablet)

      Recruiting
      • Cytomegalovirus Anterior Uveitis
      • Valganciclovir Hydrochloride
      • +3 more
      • San Francisco, California
        Proctor Foundation, UCSF
      Jul 1, 2022

      Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

      Recruiting
      • Hepatitis B
      • HIV Infections
      • San Diego, California
      • +35 more
      Jan 31, 2023

      HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)

      Recruiting
      • HIV Infections
      • Standard of Care (SOC) Oral ART
      • +6 more
      • Birmingham, Alabama
      • +34 more
      Dec 1, 2021

      Treatment Optimization of Refractory

      Recruiting
      • Hepatitis B, Chronic
      • Virus Diseases
      • original therapy
      • rescue therapy
      • Ankang, China
      • +12 more
      Feb 1, 2023

      Antiviral Therapy for Patients With Liver Cancer After Surgery

      Recruiting
      • Hepatocellular Carcinoma
        • Changsha, Hunan, China
          Xiangya Hospital of Central South University
        Jul 19, 2022

        HIV-1-infection Trial in Mbeya (ART, 10E8.4/iMab, VRC07-523LS)

        Not yet recruiting
        • HIV-1-infection
        • Mbeya, Tanzania
          National Institute for Medical Research-Mbeya Medical Resarch Ce
        Jun 6, 2023

        Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

        Recruiting
        • Diabetes Mellitus
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 27, 2023

        COVID-19 Trial in London (Favipiravir, Lopinavir/ Ritonavir, Favipiravir Placebo)

        Completed
        • COVID-19
        • London, United Kingdom
        • +1 more
        Dec 12, 2022

        Stopping Antiviral Treatment in Chronic Hepatitis B

        Recruiting
        • Chronic Hepatitis b
        • Hong Kong, Please Select One ..., Hong Kong
          Man Fung Yuen
        Sep 28, 2021

        HCV-TARGET- Hepatitis C Therapeutic Registry and Research

        Active, not recruiting
        • Hepatitis C
          • Phoenix, Arizona
          • +59 more
          Oct 5, 2022

          Anticoagulants; Increased Trial (Apixaban)

          Not yet recruiting
          • Anticoagulants; Increased
          • (no location specified)
          May 14, 2021

          Hemorrhage, Intracranial Hemorrhages, Bleeding Trial in Austin (Anticoagulants)

          Not yet recruiting
          • Hemorrhage
          • +3 more
          • Austin, Texas
            Dell Seton Medical Center at The University of Texas
          May 14, 2021

          Oral Mucositis, Childhood Acute Lymphoblastic Leukemia Trial (Laser Therapy, Sham procedure)

          Not yet recruiting
          • Oral Mucositis
          • Childhood Acute Lymphoblastic Leukemia
          • Laser Therapy
          • Sham procedure
          • (no location specified)
          Jul 7, 2022

          Periodontitis Trial in Cairo (Azadirachta Indica, Non Surgical Periodontal Therapy)

          Completed
          • Periodontitis
          • Azadirachta Indica
          • Non Surgical Periodontal Therapy
          • Cairo, Egypt
            Faculty of Dentistry -Ain Shams University
          Sep 17, 2023